| 29891332
|
Experimental infection of human volunteers. |
Lancet Infect Dis |
2018 |
Roestenberg M;Hoogerwerf MA;Ferreira DM;Mordmuller B;Yazdanbakhsh M |
View
More |
| 30461192
|
Toward development of generic inhibitors against the 3C proteases of picornaviruses. |
FEBS J |
2019 |
Banerjee K;Bhat R;Rao VUB;Nain A;Rallapalli KL;Gangopadhyay S;Singh RP;Banerjee M;Jayaram B |
View
More |
| 31185007
|
A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses. |
PLoS Biol |
2019 |
Abdelnabi R;Geraets JA;Ma Y;Mirabelli C;Flatt JW;Domanska A;Delang L;Jochmans D;Kumar TA;Jayaprakash V;Sinha BN;Leyssen P;Butcher SJ;Neyts J |
View
More |
| 32320825
|
Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status. |
Infect Genet Evol |
2020 |
Abd El-Aziz TM;Stockand JD |
View
More |
| 34857794
|
Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus disease. |
Sci Rep |
2021 |
Sugiyama MG;Cui H;Redka DS;Karimzadeh M;Rujas E;Maan H;Hayat S;Cheung K;Misra R;McPhee JB;Viirre RD;Haller A;Botelho RJ;Karshafian R;Sabatinos SA;Fairn GD;Madani Tonekaboni SA;Windemuth A;Julien JP;Shahani V;MacKinnon SS;Wang B;Antonescu CN |
View
More |
